These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38866243)

  • 1. Targeted treatment for biofilm-based infections using PEGylated tobramycin.
    Ding L; Wang G; Wang J; Peng Y; Cai S; Khan SU; Cui Z; Zhang X; Wu C; Smyth H
    J Control Release; 2024 Aug; 372():43-58. PubMed ID: 38866243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylation of Tobramycin Improves Mucus Penetration and Antimicrobial Activity against Pseudomonas aeruginosa Biofilms in Vitro.
    Bahamondez-Canas TF; Zhang H; Tewes F; Leal J; Smyth HDC
    Mol Pharm; 2018 Apr; 15(4):1643-1652. PubMed ID: 29514003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Biofilm Antimicrobial Activity of Polyethylene Glycol Conjugated Tobramycin Compared to Tobramycin in Pseudomonas aeruginosa Biofilms.
    Du J; Bandara HM; Du P; Huang H; Hoang K; Nguyen D; Mogarala SV; Smyth HD
    Mol Pharm; 2015 May; 12(5):1544-53. PubMed ID: 25793309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Aerosolized Rifaximin versus Tobramycin for Treatment of Pseudomonas aeruginosa Pneumonia in Mice.
    Kirby BD; Al Ahmar R; Withers TR; Valentine ME; Valentovic M; Long TE; Gaskins JR; Yu HD
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010865
    [No Abstract]   [Full Text] [Related]  

  • 5. Bismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosa.
    Halwani M; Hebert S; Suntres ZE; Lafrenie RM; Azghani AO; Omri A
    Int J Pharm; 2009 May; 373(1-2):141-6. PubMed ID: 19429299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual tobramycin and docosahexaenoic acid loaded nanoemulsions combating Pseudomonas aeruginosa-induced pulmonary infection.
    Sun Y; Lu T; Pan J; He H; Xu M; Chen Y; Chen Y; Fang P; Ye X; Li S; Hu H; Yu S
    Colloids Surf B Biointerfaces; 2024 Oct; 242():114088. PubMed ID: 39003845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling.
    Bilal H; Tait JR; Lang Y; Zhou J; Bergen PJ; Peleg AY; Bulitta JB; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2022 Mar; 66(3):e0220321. PubMed ID: 35041509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bismuth-ethanedithiol incorporated in a liposome-loaded tobramycin formulation modulates the alginate levels in mucoid Pseudomonas aeruginosa.
    Alipour M; Dorval C; Suntres ZE; Omri A
    J Pharm Pharmacol; 2011 Aug; 63(8):999-1007. PubMed ID: 21718282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobramycin-mediated self-assembly of DNA nanostructures for targeted treatment of
    Xu Y; Liu Q; Wang B; Li Q; Chen Y; Yang Y; Zhu Z; Gong D; Zhang C; Wang G; Qian H
    Biomater Sci; 2024 Apr; 12(9):2331-2340. PubMed ID: 38488889
    [No Abstract]   [Full Text] [Related]  

  • 10. Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
    Rojo-Molinero E; Macià MD; Rubio R; Moyà B; Cabot G; López-Causapé C; Pérez JL; Cantón R; Oliver A
    Antimicrob Agents Chemother; 2016 May; 60(5):2912-22. PubMed ID: 26926631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial efficacy of tobramycin polymeric nanoparticles for Pseudomonas aeruginosa infections in cystic fibrosis: formulation, characterisation and functionalisation with dornase alfa (DNase).
    Deacon J; Abdelghany SM; Quinn DJ; Schmid D; Megaw J; Donnelly RF; Jones DS; Kissenpfennig A; Elborn JS; Gilmore BF; Taggart CC; Scott CJ
    J Control Release; 2015 Jan; 198():55-61. PubMed ID: 25481442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms.
    Armijo LM; Wawrzyniec SJ; Kopciuch M; Brandt YI; Rivera AC; Withers NJ; Cook NC; Huber DL; Monson TC; Smyth HDC; Osiński M
    J Nanobiotechnology; 2020 Feb; 18(1):35. PubMed ID: 32070354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin-coated pH-responsive dimeric prodrug-based nano-assemblies with high biofilm eradication capacity.
    Li X; Li W; Li K; Chen X; Wang C; Qiao M; Hong W
    Biomater Sci; 2023 Jan; 11(3):1031-1041. PubMed ID: 36545821
    [No Abstract]   [Full Text] [Related]  

  • 14. Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis-Related Pseudomonas aeruginosa Biofilms.
    Thorn CR; Carvalho-Wodarz CS; Horstmann JC; Lehr CM; Prestidge CA; Thomas N
    Small; 2021 Jun; 17(24):e2100531. PubMed ID: 33978317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
    Bilal H; Bergen PJ; Kim TH; Chung SE; Peleg AY; Oliver A; Nation RL; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squalenyl Hydrogen Sulfate Nanoparticles for Simultaneous Delivery of Tobramycin and an Alkylquinolone Quorum Sensing Inhibitor Enable the Eradication of P. aeruginosa Biofilm Infections.
    Ho DK; Murgia X; De Rossi C; Christmann R; Hüfner de Mello Martins AG; Koch M; Andreas A; Herrmann J; Müller R; Empting M; Hartmann RW; Desmaele D; Loretz B; Couvreur P; Lehr CM
    Angew Chem Int Ed Engl; 2020 Jun; 59(26):10292-10296. PubMed ID: 32243047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyester-based particles to overcome the obstacles of mucus and biofilms in the lung for tobramycin application under static and dynamic fluidic conditions.
    Ernst J; Klinger-Strobel M; Arnold K; Thamm J; Hartung A; Pletz MW; Makarewicz O; Fischer D
    Eur J Pharm Biopharm; 2018 Oct; 131():120-129. PubMed ID: 30063969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa.
    Murphy RA; Coates M; Thrane S; Sabnis A; Harrison J; Schelenz S; Edwards AM; Vorup-Jensen T; Davies JC
    Microbiol Spectr; 2022 Aug; 10(4):e0081322. PubMed ID: 35727066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa.
    Herrmann G; Yang L; Wu H; Song Z; Wang H; Høiby N; Ulrich M; Molin S; Riethmüller J; Döring G
    J Infect Dis; 2010 Nov; 202(10):1585-92. PubMed ID: 20942647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infection.
    Alhariri M; Omri A
    Antimicrob Agents Chemother; 2013 Jan; 57(1):569-78. PubMed ID: 23147741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.